Medpace Holdings (MEDP) Other Accumulated Expenses (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Other Accumulated Expenses data on file, last reported at $42.1 million in Q2 2026.

• Quarterly Other Accumulated Expenses fell 6.19% year-over-year to $42.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $42.1 million (down 6.19% YoY) and the FY2025 annual result came in at $52.8 million, down 1.49% from the prior year.
• Other Accumulated Expenses retreated to $42.1 million in Q2 2026, from $48.2 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $62.5 million in Q1 2023 to a low of $25.9 million in Q2 2022.
• A 5-year average of $43.6 million and a median of $43.4 million in 2024 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2023 — Other Accumulated Expenses surged 96.94% — and 2024, when it decreased 28.65%.
• Tracing MEDP's Other Accumulated Expenses over 5 years: stood at $47.5 million in 2022, then slipped by 14.95% to $40.4 million in 2023, then surged by 32.62% to $53.6 million in 2024, then retreated by 1.49% to $52.8 million in 2025, then declined by 20.31% to $42.1 million in 2026.
• The last three Other Accumulated Expenses figures came in at $42.1 million (Q2 2026), $48.2 million (Q1 2026), and $52.8 million (Q4 2025), per Business Quant data.